These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33069055)

  • 21. Glycyrrhiza glabra extract and quercetin reverses cisplatin resistance in triple-negative MDA-MB-468 breast cancer cells via inhibition of cytochrome P450 1B1 enzyme.
    Sharma R; Gatchie L; Williams IS; Jain SK; Vishwakarma RA; Chaudhuri B; Bharate SB
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5400-5403. PubMed ID: 29150398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Oxidation on Berberine-Mediated CYP1 Inhibition: Oxidation Behavior and Metabolite-Mediated Inhibition.
    Lo SN; Shen CC; Chang CY; Tsai KC; Huang CC; Wu TS; Ueng YF
    Drug Metab Dispos; 2015 Jul; 43(7):1100-7. PubMed ID: 25953522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential inhibition of CYP1-catalyzed regioselective hydroxylation of estradiol by berberine and its oxidative metabolites.
    Chang YP; Huang CC; Shen CC; Tsai KC; Ueng YF
    Drug Metab Pharmacokinet; 2015 Oct; 30(5):374-83. PubMed ID: 26403084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quinazoline derivatives as selective CYP1B1 inhibitors.
    Mohd Siddique MU; McCann GJ; Sonawane VR; Horley N; Gatchie L; Joshi P; Bharate SB; Jayaprakash V; Sinha BN; Chaudhuri B
    Eur J Med Chem; 2017 Apr; 130():320-327. PubMed ID: 28259840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.
    Horley NJ; Beresford KJ; Chawla T; McCann GJ; Ruparelia KC; Gatchie L; Sonawane VR; Williams IS; Tan HL; Joshi P; Bharate SS; Kumar V; Bharate SB; Chaudhuri B
    Eur J Med Chem; 2017 Mar; 129():159-174. PubMed ID: 28222316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification.
    Wang Y; He X; Li C; Ma Y; Xue W; Hu B; Wang J; Zhang T; Zhang F
    Eur J Med Chem; 2020 May; 193():112235. PubMed ID: 32203789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural characterization of the complex between alpha-naphthoflavone and human cytochrome P450 1B1.
    Wang A; Savas U; Stout CD; Johnson EF
    J Biol Chem; 2011 Feb; 286(7):5736-43. PubMed ID: 21147782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico guided designing of optimized benzochalcones derivatives as potent CYP1B1 inhibitors: An integrated in vitro and ONIOM study.
    Sharma H; Raju B; Narendra G; Kumar M; Verma H; Sharma B; Tung GK; Kumar Jain S; Brás NF; Silakari O
    J Mol Graph Model; 2023 Mar; 119():108390. PubMed ID: 36502606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of Cytochrome P450 1B1 Inhibitors
    Hachey AC; Fenton AD; Heidary DK; Glazer EC
    J Med Chem; 2023 Jan; 66(1):398-412. PubMed ID: 36520541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candidate cytochrome P450 genes for ethoxyresorufin O-deethylase activity in oyster Crassostrea gigas.
    Siebert MN; Mattos JJ; Toledo-Silva G; Razzera G; Bainy ACD
    Aquat Toxicol; 2017 Aug; 189():142-149. PubMed ID: 28623690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitidine Chloride-Induced CYP1 Enzyme Inhibition and Alteration of Estradiol Metabolism.
    Mao X; Wang J; Wang Q; Yang L; Li Y; Lin H; Peng Y; Zheng J
    Drug Metab Dispos; 2019 Aug; 47(8):919-927. PubMed ID: 31147316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of aromatase cytochrome P-450 (estrogen synthetase) by derivatives of alpha-naphthoflavone.
    Kellis JT; Nesnow S; Vickery LE
    Biochem Pharmacol; 1986 Sep; 35(17):2887-91. PubMed ID: 3741479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytochrome P450 CYP1 metabolism of hydroxylated flavones and flavonols: Selective bioactivation of luteolin in breast cancer cells.
    Wilsher NE; Arroo RR; Matsoukas MT; Tsatsakis AM; Spandidos DA; Androutsopoulos VP
    Food Chem Toxicol; 2017 Dec; 110():383-394. PubMed ID: 29097115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
    Lin H; Hu B; He X; Mao J; Wang Y; Wang J; Zhang T; Zheng J; Peng Y; Zhang F
    Biochem Pharmacol; 2020 Jan; 171():113733. PubMed ID: 31783010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of pyrrole-based chalcones as CYP1 enzyme inhibitors, for possible prevention of cancer and overcoming cisplatin resistance.
    Williams IS; Joshi P; Gatchie L; Sharma M; Satti NK; Vishwakarma RA; Chaudhuri B; Bharate SB
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3683-3687. PubMed ID: 28711350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment.
    D'Uva G; Baci D; Albini A; Noonan DM
    Cancer Treat Rev; 2018 Feb; 63():1-18. PubMed ID: 29197745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-Based Design and Synthesis of New Estrane-Pyridine Derivatives as Cytochrome P450 (CYP) 1B1 Inhibitors.
    Dutour R; Cortés-Benítez F; Roy J; Poirier D
    ACS Med Chem Lett; 2017 Nov; 8(11):1159-1164. PubMed ID: 29152048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.
    Kim S; Ko H; Park JE; Jung S; Lee SK; Chun YJ
    J Med Chem; 2002 Jan; 45(1):160-4. PubMed ID: 11754588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of an ancestral mammalian family 1B1 cytochrome P450 with increased thermostability.
    Bart AG; Harris KL; Gillam EMJ; Scott EE
    J Biol Chem; 2020 Apr; 295(17):5640-5653. PubMed ID: 32156703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP1B1: A Promising Target in Cancer Drug Discovery.
    Fabris M; Luiza Silva M; de Santiago-Silva KM; de Lima Ferreira Bispo M; Goes Camargo P
    Anticancer Agents Med Chem; 2023; 23(9):981-988. PubMed ID: 36655529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.